Cronos Group Inc vs GoPro Inc — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while GoPro Inc trades at $1.19 (market cap $243.50M). The key difference: Cronos Group Inc is far larger — about 4.8× GoPro Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, GoPro Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and GoPro Inc for 45 Days on average.
| CRON | GPRO | |
|---|---|---|
Market Cap | $1.18B | $243.50M |
Volume | 968,037 | 11,527,160 |
Sector | Health | Technology |
52-Week High | $3.55 | $2.35 |
52-Week Low | $2.30 | $0.58 |
Typical Hold Time | 22 Days | 45 Days |
Enterprise Value | $387.62M | $302.28M |
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% on the day, with a bearish technical signal and neutral oscillators. The company reported a net loss of $9.45M in 2025 despite revenue growth to $146.59M, but recent quarters show earnings beats. Analyst sentiment is mixed with 20% buy, 60% hold, and 20% sell ratings. Recent news highlights investor day events and international expansion efforts.
The outlook is cautious; profitability improvements and cash flow generation are key catalysts, but high valuation multiples and negative net cash flow pose risks. Regulatory developments in cannabis markets and execution on growth targets will be critical for stock performance.
GoPro (GPRO) trades at $1.22, down 7.58% on the day, amid volatile trading following a recent surge driven by merger news and influencer investment. The stock shows bullish technical signals with oversold RSI conditions, but fundamentals remain weak with declining revenues and persistent net losses. Recent developments include a proposed $285 million merger with Starman Optical and significant stake acquisition by YouTube creator Markiplier, creating both opportunity and uncertainty for shareholders.
The outlook remains highly speculative with the merger offering potential upside but facing shareholder litigation over valuation concerns. Key risks include continued operational losses, competitive pressures from smartphones, and merger execution challenges. Analyst sentiment is mixed with only 21% buy ratings, reflecting skepticism about the company's standalone prospects versus merger-driven speculation.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
Read more on GPRO →